Voglitab 0.2 Tablet
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Voglibose (0.2mg)
Overview Voglitab 0.2 Tablet
Diabetic patients with type 2 mellitus may find relief with the medication, Voglitab 0.2mg tablets. This treatment helps regulate elevated blood glucose following meals, particularly when dietary adjustments and other comparable medications prove insufficient. Administer Voglitab 0.2mg just prior to eating; dosage and frequency should be determined by your physician for optimal blood sugar management. Abrupt cessation is strongly discouraged; consult your doctor first to avoid potentially serious complications like vision impairment or kidney issues stemming from uncontrolled hyperglycemia. Remember, Voglitab 0.2mg is one component of a comprehensive diabetes management plan encompassing healthy eating, exercise, and weight management as directed by your physician. Regular blood glucose monitoring is essential while using this medication. Commonly reported side effects include abdominal discomfort, flatulence, appetite changes, constipation, and diarrhea. Report any persistent or bothersome side effects to your healthcare provider. While Voglitab 0.2mg alone doesn't induce hypoglycemia, its concurrent use with other antidiabetic agents (especially insulin or sulfonylureas) increases this risk. In such instances, treat hypoglycemia with plain glucose; table sugar is ineffective. Inform your doctor of any liver or kidney conditions before commencing treatment. Patients with inflammatory bowel diseases (e.g., Crohn's disease or ulcerative colitis) should not use this medication. Pregnant or breastfeeding individuals must consult their physician. For safety, disclose all other medications currently being used. Limit alcohol consumption as it may elevate the likelihood of hypoglycemia.
Uses of Voglitab 0.2 Tablet
Managing type 2 diabetes
Major Benefits of Voglitab 0.2 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Voglitab 0.2 Tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
Common Side effects of Voglitab 0.2 Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Voglitab 0.2 Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Voglitab 0.2 Tablets should be administered on an empty stomach.
How Voglitab 0.2 Tablet works:
Glimepiride 0.2mg tablets are used to manage diabetes. They work by blocking intestinal enzymes that digest complex carbohydrates, thus preventing post-meal spikes in blood sugar.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol and Voglitab 0.2 Tablet should not be taken together.
PregnancySAFE IF PRESCRIBED
The use of Voglitab 0.2 Tablet during pregnancy is typically regarded as safe. Preclinical trials in animals have revealed minimal or no negative consequences for fetal development; nevertheless, research involving human subjects is scarce.
Breast feedingSAFE IF PRESCRIBED
The use of Voglitab 0.2 Tablet while breastfeeding appears to pose minimal risk. Available human data indicates negligible danger to the infant.
DrivingSAFE
Driving ability is typically unaffected by Voglitab 0.2 Tablets.
KidneyCAUTION
Exercise caution when administering Voglitab 0.2 Tablet to individuals with advanced renal impairment. Dosage modification for Voglitab 0.2 Tablet may be necessary. Physician consultation is recommended.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Voglitab 0.2mg tablets. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Voglitab 0.2 Tablet :
Omit any missed Voglitab 0.2 Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Voglitab 0.2 Tablet
| Label | Value |
|---|---|
| Chemical Classification | Valiolamine analog |
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
| Actions | Alpha-glucosidase inhibitors |
3,018 People bought this recently